Systemic and large local reactions during subcutaneous grass pollen immunotherapy in children

被引:11
作者
Gur Cetinkaya, Pinar [1 ]
Kahveci, Melike [1 ]
Esenboga, Saliha [1 ]
Karaatmaca, Betul [1 ]
Soyer, Ozge [1 ]
Sekerel, Bulent Enis [1 ]
Tuncer, Ayfer [1 ]
Sahiner, Umit Murat [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Pediat, Div Pediat Allergy & Asthma Unit, Ankara, Turkey
关键词
adverse reactions; allergic rhinitis; children; pollen; subcutaneous immunotherapy; ALLERGEN IMMUNOTHERAPY; FATAL REACTIONS; RISK-FACTORS; EXTRACTS; IMPACT; INJECTIONS; RHINITIS;
D O I
10.1111/pai.13261
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background Subcutaneous immunotherapy (SCIT) is the allergen-specific curative treatment of allergic rhinitis. Adverse effects, most of which are local, can be observed during the immunotherapy. These adverse effects have been reported more frequently during the pollen season. The purpose of this study was to estimate the rate of local, large local, and systemic reactions during the treatment, to determine the relationship between adverse reactions and the season in which these reactions occur, as well as the risk factors for adverse reactions during the grass pollen-specific SCIT treatment in children. Methods We retrospectively collected and analyzed the data of 261 children who administered grass pollen SCIT between 2008 and 2018. Results A total of 261 children (177, 67.8% male), who received grass pollen SCIT, with a mean (+/- SD) age of 12.0 +/- 3.0 years at the initiation of SCIT were enrolled to the study. The number of the patients who experienced local and large local reactions was 109 and 30, respectively. In addition, the number of the patients with systemic reactions was 35. After the 12 284 injections, local reactions occurred in 357 (2.9%), and this was followed by systemic reaction as 55 (0.4%) and large local reactions as 40 (0.3%). Frequency of local (P 001) and systemic reactions (P = .003) was higher during grass pollen season than out of the grass pollen season. In multivariate analysis, initiation of SCIT during the grass pollen season [OR:7.351, 95%CI:1.532-35.279, P = .013] and experiencing local reactions [OR:4.214, 95%CI:2.159-8.224, P < .001] were independent predictors for the development of large local and systemic reactions. Conclusion SCIT, in which only mild-to-moderate systemic reactions occurred, is safe for the treatment of allergic rhinitis in children. Our study revealed that previous local reactions and initiation of immunotherapy during the grass pollen season were the predictors for large local and systemic reactions during SCIT in children.
引用
收藏
页码:643 / 650
页数:8
相关论文
共 50 条
  • [31] Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy
    Valovirta, Erkka
    Petersen, Thomas H.
    Piotrowska, Teresa
    Laursen, Mette K.
    Andersen, Jens S.
    Sorensen, Helle F.
    Klink, Rabih
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : 529 - +
  • [32] Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study
    Klimek, L.
    Schendzielorz, P.
    Pinol, R.
    Pfaar, O.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2012, 42 (06) : 936 - 945
  • [33] Efficacy of epinephrine and diphenhydramine rinses in decreasing local reactions to subcutaneous aeroallergen immunotherapy
    Mustafa, S. Shahzad
    Vadamalai, Karthik
    Bingemann, Theresa
    Ramsey, Allison
    ALLERGY AND ASTHMA PROCEEDINGS, 2020, 41 (01) : 52 - 58
  • [34] AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?
    Epstein, Tolly G.
    Liss, Gary M.
    Murphy-Berendts, Karen
    Bernstein, David I.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 110 (04) : 274 - +
  • [35] The Local and Systemic Reactions Due to Sublingual Immunotherapy: Is Anaphylaxis Associated with Therapy?
    Ozdemir, Oner
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2015, 14 (02) : 228 - 230
  • [36] Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract
    Schmid, Johannes Martin
    Wurtzen, Peter Adler
    Dahl, Ronald
    Hoffmann, Hans Jurgen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : 562 - 570
  • [37] The local and systemic side-effects of venom and inhaled-allergen subcutaneous immunotherapy
    Adamic, Katja
    Zidarn, Mihaela
    Bajrovic, Nissera
    Erzen, Renato
    Kopac, Peter
    Music, Ema
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 (9-10) : 357 - 360
  • [38] The relevance of patient-reported outcomes in a grass pollen immunotherapy trial in children and adolescents with rhinoconjunctivitis
    Roder, Esther
    Berger, Marjolein Y.
    Hop, Wim C. J.
    de Groot, Hans
    van Wijk, Roy Gerth
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2013, 24 (01) : 39 - +
  • [39] Allergen Immunotherapy for a Teenager with Seasonal Allergic Rhinitis Due to Grass Pollen: Subcutaneous or Sublingual Route?
    Nelson, Harold S.
    Durham, Stephen R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2017, 5 (01) : 52 - 57
  • [40] Seasonal increases in peripheral innatelymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy
    Lao-Araya, Mongkol
    Steveling, Esther
    Scadding, Guy W.
    Durham, Stephen R.
    Shamji, Mohamed H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 134 (05) : 1193 - 1195